SCHEMBL18859547

SCHEMBL18859547

c1cc2ccc3cc(-c4ccc(-c5nc6c7ccccc7sc6c6ccccc56)cc4)cc4ccc(c1)c2c34

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 2/20 0.38
▸ TNKS2 Q9H2K2 2/20 0.38
▸ ALOX5 P09917 1/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ FYN P06241 1/20 0.36
▸ MAOA P21397 1/20 0.36
▸ ACHE P22303 1/20 0.36
▸ AHR P35869 1/20 0.36
▸ NQO1 P15559 1/20 0.35
▸ NQO2 P16083 1/20 0.35
▸ LIMK1 P53667 3/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ PIM1 P11309 2/20 0.33
▸ PIM2 Q9P1W9 2/20 0.33
▸ KRAS P01116 1/20 0.33
▸ HRH4 Q9H3N8 2/20 0.32
▸ EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18859542 0.88 TNKS (0.40) TNKSTNKS2ALOX5CYP1A2LIMK1
SCHEMBL18859549 0.82 TNKS (0.38) TNKSTNKS2ALOX5CYP1A2NQO1
SCHEMBL18859556 0.81 TNKS (0.40) TNKSTNKS2ALOX5LIMK1CDK5
SCHEMBL22274026 0.81 MEN1 (0.35) TNKSTNKS2ALOX5LIMK1MAPT
SCHEMBL18859782 0.80 TNKS (0.43) TNKSTNKS2LIMK1CDK5CDK5R1
SCHEMBL24280201 0.80 LIMK1 (0.39) TNKSTNKS2CYP1A2NQO1NQO2
SCHEMBL22274035 0.79 MEN1 (0.36) TNKSTNKS2ALOX5CYP1A2ERBB2
SCHEMBL22273916 0.79 MEN1 (0.36) TNKSTNKS2ALOX5CYP1A2ERBB2
SCHEMBL18859533 0.79 TNKS (0.36) TNKSTNKS2ALOX5LIMK1CDK5
SCHEMBL18859540 0.79 ALOX5 (0.52) TNKSTNKS2ALOX5LIMK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10644244-B2 Heterocyclic compound and organic light emitting device using same LT MATERIALS CO., LTD. (KR) 2020-05-05 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141325-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME CRY1, CRY2, CYBA TNKS 1638/4885TNKS2 1814/4885ALOX5 1302/4885
US-10644244-B2 Heterocyclic compound and organic light emitting device using same CRY1, CRY2, CYBA TNKS 1638/4885TNKS2 1814/4885ALOX5 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback